Sarli, M., Novoa, M. B., Mazzucco Panizza, M. N., Signorini, M., Echaide, I. E., Echaide, S. T. d., & Primo, M. E. (2020). A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge. PLOS; National Center for Biotechnology Information.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Sarli, Macarena, María Belen Novoa, Matilde Nahimé Mazzucco Panizza, Marcelo Signorini, Ignacio Eduardo Echaide, Susana T. de Echaide, y María Evangelina Primo. A Vaccine Using Anaplasma Marginale Subdominant Type IV Secretion System Recombinant Proteins Was Not Protective Against a Virulent Challenge. PLOS; National Center for Biotechnology Information, 2020.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Sarli, Macarena, et al. A Vaccine Using Anaplasma Marginale Subdominant Type IV Secretion System Recombinant Proteins Was Not Protective Against a Virulent Challenge. PLOS; National Center for Biotechnology Information, 2020.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.